Pharmaust Ltd
ASX:PAA

Watchlist Manager
Pharmaust Ltd Logo
Pharmaust Ltd
ASX:PAA
Watchlist
Price: 0.165 AUD -8.33% Market Closed
Market Cap: 81.2m AUD

Intrinsic Value

PAA doesn't have a meaningful market cap.

The intrinsic value of one PAA stock under the Base Case scenario is 0.013 AUD. Compared to the current market price of 0.165 AUD, Pharmaust Ltd is Overvalued by 92%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PAA Intrinsic Value
0.013 AUD
Overvaluation 92%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pharmaust Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about PAA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PAA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pharmaust Ltd.

Explain Valuation
Compare PAA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PAA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaust Ltd

Current Assets 11.1m
Cash & Short-Term Investments 9.7m
Receivables 18.5k
Other Current Assets 1.4m
Current Liabilities 896k
Accounts Payable 826.9k
Other Current Liabilities 69.1k
Non-Current Liabilities 650
Other Non-Current Liabilities 650
Efficiency

Free Cash Flow Analysis
Pharmaust Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pharmaust Ltd

Revenue
866.2k AUD
Operating Expenses
-6.7m AUD
Operating Income
-5.8m AUD
Other Expenses
-1.9m AUD
Net Income
-7.7m AUD
Fundamental Scores

PAA Profitability Score
Profitability Due Diligence

Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Strong 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
13/100
Profitability
Score

Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

PAA Solvency Score
Solvency Due Diligence

Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PAA Price Targets Summary
Pharmaust Ltd

There are no price targets for PAA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Pharmaust Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PAA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PAA stock?

The intrinsic value of one PAA stock under the Base Case scenario is 0.013 AUD.

Is PAA stock undervalued or overvalued?

Compared to the current market price of 0.165 AUD, Pharmaust Ltd is Overvalued by 92%.

Back to Top